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Background: Invasive methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus
aureus (MSSA) infections are major causes of numerous neonatal intensive care unit (NICU) outbreaks. There have
been increasing reports of MRSA outbreaks in various neonatal intensive care units (NICUs) over the last decade.
Our objective was to review the experience of Staphylococcus aureus sepsis in our NICU in the last decade and
describe the trends in the incidence of Staphylococcus aureus blood stream infections from 2000 to 2009.
Methods: A retrospective perinatal database review of all neonates admitted to our NICU with blood cultures
positive for Staphylococcus aureus from (Jan 1st 2000 to December 31st 2009) was conducted. Infants were
identified from the database and data were collected regarding their clinical characteristics and co-morbidities,
including shock with sepsis and mortality. Period A represents patients admitted in 2000-2003. Period B represents
patients seen in 2004-2009.
Results: During the study period, 156/11111 infants were identified with Staphylococcus aureus blood stream
infection: 41/4486 (0.91%) infants in Period A and 115/6625 (1.73%) in Period B (p < 0.0004). Mean gestation at birth
was 26 weeks for infants in both periods. There were more MRSA infections in Period B (24% vs. 55% p < 0.05) and
they were associated with more severe outcomes. In comparing the cases of MRSA infections observed in the
two periods, infants in period B notably had significantly more pneumonia cases (2.4% vs. 27%, p = 0.0005) and a
significantly higher mortality rate (0% vs. 15.7%, p = 0.0038). The incidences of skin and soft tissue infections and
of necrotizing enterocolitis were not significantly changed in the two periods.
Conclusion: There was an increase in the incidence of Staphylococcus aureus infection among neonates after 2004.
Although MSSA continues to be a problem in the NICU, MRSA infections were more prevalent in the past 6 years in
our NICU. Increased severity of staphylococcal infections and associated rising mortality are possibly related to the
increasing MRSA infections with a more virulent community-associated strain.
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Treatment of Staphylococcus aureus infections in the
neonatal intensive care unit (NICU) continues to be a
high priority, and reducing the burden of all staphylo-
coccal infections remains of utmost importance. Invasive
methicillin-sensitive (MSSA) and methicillin-resistant
(MRSA) Staphylococcus aureus bloodstream infections* Correspondence: odolapo1@uthsc.edu
Department of Pediatrics, Division of Neonatology, University of Tennessee
Health Science Center, Suite 201, 853 Jefferson Avenue, Memphis, TN
38163-0001, USA
© 2014 Dolapo et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.in the newborn present with a wide range of serious
complications. The situation is particularly worse in the
preterm infant, where the developmental immaturity of
the immune system increases the susceptibility to these
infections. Complications may include brain or visceral
abscesses, meningitis, orbital cellulitis, osteomyelitis,
septic arthritis, endocarditis, pneumatoceles and lung
abscesses, septic ileus, septic shock and, not infrequently,
death [1-5]. Numerous recent outbreaks in the NICUs
have been attributed to strains of MRSA found both in
the health care environment and in the community. TheLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Staphylococcus aureus (CA-MRSA) strains in NICU out-
breaks has been widely documented [2,4,6-9]. Earlier stud-
ies have stressed the differences between the two different
strains of MRSA originating from the hospital environ-
ment and from the community, but there are little data
available emphasizing the potential change in the epi-
demiological trend of Staphylococcus aureus blood stream
infections in the NICU, with increasing reports of MRSA
outbreaks [1,4,8,10-13].
There were reports by the Center for Disease Control
(CDC) in the United States showing a series of outbreaks
in the NICU of potential new strains of community-ac-
quired MRSA in and around the year 2004 [1,6]. This was
also corroborated by Healy et al. [4] in their study in the
same period [4].
This study identifies the unique epidemiological char-
acteristics and trends in the incidence of Staphyloccus
aureus blood stream infections in neonates, with a view
to developing strategies to further decrease the risks of
infection. We reviewed our data from 2000-2009, and di-
vided it into cohorts based on references to the in-
creased incidence of MRSA in 2004 in several NICUs.
Methods
This was a retrospective study carried out in a level III
NICU in Memphis, Tennessee, USA – The Regional Med-
ical Center at Memphis. The study was done in a 70-bed
NICU with a median annual admission rate of 1110 (range
1006 – 1200) admissions per year during the study period
(2000-2009). Very low birth weight (VLBW) infant admis-
sion rate was about 200 per year. The study was approved
by the hospital Institutional Review Board (Reference: 11-
01514-XM). The NICU perinatal database was used to cre-
ate a list of infants hospitalized in the NICU with positive
blood culture for Staphylococcus aureus (both MSSA and
MRSA) in this period. A chart review of all neonates admit-
ted to the NICU with staphylococcal blood stream infection
from January 1st 2000 to December 31st 2009 was done.
Subjects were classified into two groups based on the
date of hospital admission using the year 2004 as a refer-
ence point, which was the year from which earlier reports
of MRSA outbreaks in the NICU were documented.
We compared the demographics, clinical characteris-
tics and outcomes of staphylococcal blood stream infec-
tions in the periods before and after reported outbreaks
of MRSA in the NICU over the last decade. Period A
represents infants admitted from January 1st 2000 to
December 31st 2003, and Period B comprises infants ad-
mitted from January 1st 2004 to December 31st 2009.
Study design
Data such as gestational age, birth weight, sex, age at diag-
nosis with a positive blood culture for S. aureus, durationof hospitalization, mechanical ventilation and therapy for
respiratory distress syndrome, and use of invasive proce-
dures (including umbilical catheterizations and central
venous catheter placements) were collected for the study.
Clinical features including pneumonia, skin and soft tissue
infections and complications of infection (such as oc-
currence of septic shock and mortality) were included in
the data.
Staphylococcus aureus infection or colonization of
other body sites, such as skin, anterior nares, conjunctiva,
etc., without concomitant positive bloodstream cultures
were excluded from the study.
Data regarding antibiotic susceptibility patterns were
collected for the following antibiotics – penicillin, oxacil-
lin, vancomycin and clindamycin. Inducible resistance to
clindamycin by the D-zone test was performed on isolates
with erythromycin resistance and clindamycin susceptibil-
ity. Isolates were categorized into susceptible and resistant
groups.
Definitions of variables
The diagnosis of pneumonia was considered if clinical
criteria were met (acute clinical deterioration, pulse
oximetry, increased respiratory support requirement),
radiological findings (presence of new or changing infil-
trate on chest radiography) and laboratory parameters
(elevated C-reactive protein or abnormal white cell count)
suggestive of bacterial infection.
Necrotizing enterocolitis (NEC) was only considered if
there were features of stage II NEC or higher, based on
modified Bell’s criteria [14].
Skin or soft tissue infections were identified based
on the individual clinical team’s evaluation and diag-
nosis. Septic shock was defined as the occurrence of
hypotension with evidence of sepsis in the presence
of a positive blood culture, with or without signs of
end-organ dysfunction. It was also identified as shock
occurring within 48 hours of positive blood culture.
Mortality related to sepsis was considered if it occurred
within 14 days of positive culture. Infection rates were
expressed as the number of infants infected per 1000
NICU admissions.
Statistical analyses were carried out using chi squared
tests to compare categorical variables between groups
and the extended Mantel-Haenszel chi squared test for
linear trend [15] was used to analyze the trend data.
Continuous variables were compared using medians of
variables and the interquartile range. Statistical signifi-
cance was set at p < 0.05.
Results
During the study period, 156 (1.4%) of 11,111 NICU in-
fants were identified with Staphylococcus aureus blood
stream infection. Period A (Jan 1st 2000 – Dec 31st 2003)
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while Period B (Jan 1st 2004 – Dec 31st 2009), had signifi-
cantly higher number with 115 (1.73%) cases, of a total of
6,625 infants (p = 0.004).
In 2007, education on hygiene and hand-washing
methods was intensified and the use of vancomycin
locks was introduced (later discontinued in 2009).
Otherwise, there were no other changes in the care
provided in the two study periods. The total length of
stay for VLBW infants in our NICU did not seem to
change over time and ranged between 48-61 days
mean duration, being 54.7 days in 2000 and 61.6 days
in 2009.
As shown in Table 1, the median birth weight and
gestation of infants in both periods, irrespective of
MSSA or MRSA infection, were similar. The frequency
of exposure to invasive procedures and devices was also
identical in the two periods (87.8% vs 87.8%) p = 1.000.
Mean duration of umbilical catheter days was similar
(7.89 ± 6.62 days vs. 7.10 ± 7.23 days) p = 0.543. There
was no significant difference in the mechanical ventilationTable 1 Characteristics of infants with Staphylococcus aureus
Period A (n = 4
Characteristics MSSA (n = 31)
Birth weight (g)
Median (25th-75th percentile) 752 (553-977)
Category, n (%)
<750 16 (52)
751 – 1000 7 (23)
1001 – 1250 2 (6)
1251 – 1500 2 (6)
>1500 4 (13)
Gestational age (weeks)







Male (%) 12 (39)
Female (%) 17 (61)
Frequency of invasive procedures
n (%) 27 (87)
Mechanical ventilation
n (%) 29 (94)
Age at diagnosis (days)
Median 27requirements of cohorts in both periods (92.7% vs. 93.0%)
p = 1.000. Table 2 shows the sepsis-related mortality
in different birth weight groups with both MRSA and
MSSA infections. The risk for mortality does not de-
crease with increasing birth weight with MRSA infec-
tions (p = 0.16) as compared to MSSA, where mortality
was significantly lower with increasing birth weight
(p < 0.05).
MRSA infections were significantly higher in Period B
(24% vs. 55%, p < 0.05) and, as shown in Table 3, were
also associated with more severe outcomes. In comparing
the cases of MRSA infections observed in these two
periods, infants in period B notably had a significantly
higher incidence of pneumonia (2.4% vs. 27%, p = 0.0005)
and a significantly higher mortality rate (0% vs. 15.7%,
p = 0.0038). The incidences of skin and soft tissue in-
fections and that of necrotizing enterocolitis were not
significantly different in the two periods. Period B was
associated with an increasing trend of septic shock com-
plications, although this was not statistically different from
Period A.infection during the two study periods
1) Period B (n = 115)
MRSA (n = 10) MSSA (n = 51) MRSA (n = 64)
737 (563-1120) 838 (647-1081) 736 (580-945)
4 (40) 21 (42) 37 (58)
0 (0) 14 (28) 17 (26)
2 (20) 8 (16) 4 (6)
2 (20) 2 (4) 1 (2)
2 (20) 5 (10) 5 (8)
27 (24-31) 27 (26-30) 27 (25-29)
3 (30) 9 (18) 20 (31)
3 (30) 25 (48) 23 (36)
2 (20) 11 (22) 13 (20)
2 (20) 6 (12) 8 (13)
5 (50) 26 (51) 32 (50)
5 (50) 25 (49) 32 (50)
9 (90) 46 (90) 55 (86)
9 (90) 47 (92) 60 (94)
25 22 25
Table 2 Survival rates among infants during the two study periods
Birth weight distribution (grams) Period A (N = 41) Period B (N = 115)
MSSA (n = 31) MRSA (n = 10) MSSA (n = 51) MRSA (n = 64)*
<750 16 4 21 37
Survived (%) 12 (75) 4 (100) 17 (81) 26 (70)
750 – 999 7 0 14 17
Survived (%) 7 (100) 0 12 (86) 12 (71)
1000 – 1499 2 2 8 4
Survived (%) 2 (100) 2 (100) 8 (100) 3 (75)
1500 - 1999 2 2 2 1
Survived (%) 2 (100) 2 (100) 2 (100) 0 (0)
≥ 2000 4 2 5 5
Survived (%) 4 (100) 2 (100) 5 (100) (100)
*Trend analysis of survival rates for MRSA and MSSA infections in the weight categories, using the extended Mantel-Haenszel chi-square for linear trend, showed a
significant risk of death when weight was <750 grams for MSSA cases (p = 0.0166), but no significant survival trend with increasing gestational age seen in
MRSA cases.
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shorter mean length of hospitalization than similarly
infected infants in period A (80.6 ± 42.39 vs. 53.6 ± 36.6
total hospital days; p = 0.0371). Infants with MSSA were
also noted to have a much shorter hospital course in
Period B (87.4 ± 40.6 vs. 55.7 ± 30.2 days; p = 0.0001).
The yearly trend of MRSA versus MSSA infections,
with the number of infected infants per 1000 NICU ad-
missions, is shown in the Figure 1. This shows an overall
rise in the incidence of Staphylococcus aureus blood
stream infections from the year 2004 in our NICU. Ana-
lyses of the trend data for MSSA and MRSA infections
over the study period were performed using the extended
Mantel-Haenszel chi-squared test for linear trend. Results
demonstrated a significant increase in trend for MRSA
infections, but not for MSSA infections. (MRSA trend
analysis p = 0.000702 vs. MSSA p = 0.229).
All Staphylococcus aureus isolates (MSSA and MRSA)
were susceptible to vancomycin. The sensitivity pattern
of MRSA to clindamycin was similar in the two periods:
60% of MRSA isolates were sensitive to clindamycin in
Period A vs. 64% in Period B.Table 3 Complications of Staphylococcus aureus blood stream
Period A (2000-2003) n
Complications MSSA (n = 31) MRSA (n
Septic shock 0 (0%) 1 (2.4
Concomitant soft tissue/skin infection 4 (9.8%) 6 (14
Pneumonia 6 (14.6%) 1 (2.4
Necrotizing enterocolitis 1 (2.4%) 4 (9.8
Mortality 4 (9.8%) 0 (0
Length of hospitalization (mean number of days) 87.4 ± 40.6 80.6 ±Discussion
According to a 2011 CDC report, the incidence of
MRSA in the community in general has increased rap-
idly in the past decade, with little or no evidence of
recent decline, despite clear evidence that invasive
MRSA infections in the health care setting is declining
[6]. The implementation of aggressive infection control
techniques in the health care environment has proved
successful in reducing the incidence of health care-
associated infections in various NICUs [8]. Our study
demonstrates a rise in the overall incidence of Staphylo-
coccus aureus blood stream infections observed in the
NICU in the last 10 years, with a peak period around
the year 2004. This period coincides with widespread re-
ports of CA-MRSA outbreaks in the NICUs [1,2,4,5,8].
The incidence of MRSA infections in the NICU is still
unacceptably high, and this may be likely linked to the
acquisition of CA-MRSA strains, which have evolved in
the community and penetrated the NICU through either
parents or care providers of the patient [8,9,16-19].
During the study period we detected that significantly
more MRSA infections were seen in the last 6 years, andinfections
= 41 Period B (2004-2009) n = 115 p value (comparing MRSA
infection in the two periods)
= 10) MSSA (n = 51) MRSA (n = 64)
%) 4 (3.5%) 13 (11.3%) 0.115
.6%) 5 (4.3%) 13 (11.3%) 0.584
%) 7 (6.1%) 31 (27.0%) 0.0005
%) 3 (2.6%) 5 (4.3%) 0.2435
%) 6 (5.2%) 18 (15.7%) 0.0038
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Figure 1 The yearly trend of MSSA and MRSA infection in the last decade, showing a significant rise in overall incidence of
Staphylococcus aureus infections in 2004. The extended Mantel-Haenszel chi-square test for linear trend also showed a significant increase in
MRSA infections over the 10-year period (p = 0.0007), but no trend in increase of MSSA infections (p = 0.229).
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severe clinical presentations and worse outcomes. In
previous studies, there was earlier onset of MRSA infec-
tions compared to MSSA infections, which was attrib-
uted to possible vertical transmission of infection [16].
This was not, however, the finding in our study, where
the median age at presentation for MSSA infections was
27 days in Period A and 22 days in Period B, while the
median age at diagnosis for MRSA infections was 25
days in the two periods.
The rate of skin and soft tissue infections was not
significantly different for either MRSA or MSSA cases
during the two periods reviewed in the study. Similar
findings were reported by Carey et al., who compared
123 infections caused by MSSA and 49 caused by MRSA
in a neonatal ICU. The rate of skin and soft tissue infec-
tions was similar for both groups at 45% [16]. However,
in our study, there may have been an underestimation of
skin and soft tissue infection cases, as those without
positive blood culture were excluded from the study.
Duration of hospital stay in the second period of our
study was significantly less than in the initial 4-year
period. It is unclear whether the increased incidence of
MRSA infections with more severe complications in the
subsequent 6 years led to increased mortality or whether
an improvement in neonatal care and management ap-
proach led to shorter hospital stay for ELBW infants. An
earlier study by Burke et al. found 164 episodes of S.
aureus bacteremia in 151 children and infants [3]. In this
study, children with MRSA infection stayed in the hos-
pital longer (with a mean of 36 days) than did childrenwith MSSA infection (mean 16.3 days). However, the
study was done in a cluster of not just neonates, but
children and infants.
In our study, the predominant weight category of all
infants with Staphylococcus aureus blood stream infec-
tion in the NICU was noted to be less than 750 g (51%
of all cases), and they were extremely preterm. Reasons
for this were described by Healy et al. [4] in an earlier
study, emphasizing risk factors for staphylococcal infec-
tions that are peculiar to extremely low birth weight in-
fants; namely, poorly developed host defense mechanisms,
central venous catheter requirements, need for endo-
tracheal or upper gastrointestinal tube placement, and
procedures that might compromise skin integrity. How-
ever, a trend analysis of mortality revealed no change in
risk with increasing birth weight in MRSA infections. The
risk of death was significantly higher in infants < 750 g
birth weight, with MSSA infections. Shane et al. [20] study,
demonstrated no significant difference in morbidity or
mortality of very low birth weight (VLBW) infants with
MRSA compared with those with MSSA bacteremia. This
conclusion probably reflected the multi-center nature of
their study, as 40% (8 out of 20) of the study centers, actu-
ally reported zero cases of MRSA infection. This also
probably demonstrated the variability in the population
and practice of these study centers.
The exposure of all infected infants in our study, to
risk factors was assessed (such as device utilization and
exposure to invasive procedures) and no difference was
found between study periods in the degree of exposure
to risk factors.
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the prevention of transmission in identified cases. The
importance of judicious compliance to standard infection
control practices such as hand hygiene, gloving, protection
of eyes, nose and mouth; gowning and appropriate hand-
ling of patient care equipment and devices cannot be
over-emphasized. Contact precautions must be adhered to
in all identified cases [6,7].
Our study emphasizes the changing pattern of S. aureus
infection in our NICU in the last decade as it relates to in-
creasing reports of MRSA outbreaks. This study is, how-
ever, limited by the inability to determine the pathological
characteristics and phage –type of isolates, as data were
retrospectively collected. The retrospective nature of data
collection inherently led to some diagnostic biases. Other
limitations that are commonly associated with retrospect-
ive chart reviews, such as incomplete documentation,
missing data and problematic verification of information
are also possible with this study.
Conclusions
In conclusion, there was an increase in the incidence of
S.aureus blood stream infections among neonates after
2003, which coincides with increasing reports of MRSA
infections in the NICU. Though, MSSA continues to be
a problem in the NICU, MRSA infections were more
prevalent in the last 6 years. The increased severity of S
aureus infection and associated rising mortality rate may
be related to increasing MRSA infections with a more
virulent community-associated strain.
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